Transforming Clinical Trial Management with the COVID-19 Prediction Dashboard
By Ben van der Schaaf, Thomas Unger, Michael Eiden, Ben Enejo, Craig Wylie, Tom Teixeira, Richard Eagar
Posted October 21, 2020 | Industry | Technology |
One of the many consequences of the COVID-19 crisis has been difficulty in continuing to enroll and run clinical trials, which typically involve large numbers of people interacting in multiple geographies. In this Executive Update, we highlight a new, risk-based predictive analytical approach, powered by machine learning.
Don’t have a login? Make one! It’s free and gives you access to all Cutter research.
Member/Guest loginForgot your password?